Vaccine

Europe will receive reduced doses of the Pfizer COVID-19 vaccine from next week, and for a period ahead, according to the Norwegian Institute of Public Health (NIPH).

NIPH is said to have received a message from Pfizer on Friday morning, informing it that Norway would be receiving 36,075 doses, as opposed to the expected 43,875 in their next week’s shipment.

The reduction is said to affect all European countries, as Pfizer reorganises its production to meet its increased intended capacity, from 1.3 billion doses yearly, to 2 billion.

As reported by FT.com, Pfizer has said that though the changes to the production line will impact shipments from late January to early February, they will provide for a significant increase in doses available for patients in late February and March.

The facility said to be effected is the Belgian facility of Puurs, where European countries, including the UK, receive their vaccines.

Pfizer has said that whilst it is working to deliver more doses that originally planned this year, expected quarterly volumes may need to be adjusted.

This comes after, on Tuesday, the European Medicines Agency said that the COVID vaccine manufactured by AstraZeneca and Oxford may be greenlighted for distribution by 29th January. AstraZeneca intends to manufacture up to 3 billion doses by the end of 2021.

Unpacking Malta’s new American-style bankruptcy framework

April 19, 2024
by Robert Fenech

The EU is reforming its insolvency rules to adopt some of the most beneficial elements of the US framework

More than half of all workplace deaths in last two years involved construction

April 19, 2024
by Robert Fenech

No women died on the job in 2022 and 2023

Government shells out close to €70 million to national bus operator Malta Public Transport in 2023

April 18, 2024
by Robert Fenech

Buses became free for residents in late 2022, leading to a hefty increase in the public subsidy